Abstract
Background
Endoscopic retrograde cholangiopancreatography (ERCP) can be challenging in patients with decompensated cirrhosis (DC) due to increased risk of adverse events related to liver dysfunction. Limited data exist regarding its national utilization in patients with DC. We aim to determine the trends in utilization and outcomes of ERCP among patients with DC in US hospitalizations.
Methods
We identified hospitalizations undergoing ERCP (diagnostic and therapeutic) between 2000 and 2013 from the National Inpatient Sample (NIS) database and used validated ICD9-CM codes to identify DC hospitalizations. We utilized Cochrane–Armitage test to identify changes in trends and multivariable survey regression modeling for adjusted odds ratios (aOR) for adverse outcomes and mortality predictors.
Results
There were 43782 cases of ERCPs performed in DC patients during the study period. Absolute number of ERCPs performed in this population from 2000 to 2013 showed an upward trend; however, the proportion of DC patients undergoing ERCP remained stable. We noted significant decrease in utilization of diagnostic ERCP and an increase of therapeutic ERCPs (P < 0.01). There was a significant decrease in the mean length of stay for DC patients undergoing ERCP from 8.2 days in 2000 to 7.2 days in 2013 (P < 0.01) with an increase in the mean cost of hospitalization from $17053 to $19825 (P < 0.001). Mortality rates showed a downward trend from 2000 to 2013 from 13.6 to 9.6% (P < 0.01). Increasing age, Hispanic race, diagnosis of hypertension and diabetes mellitus, and private insurance were related to adverse discharges(P < 0.01). Increasing age, presence of hepatic encephalopathy, and sepsis were associated with higher mortality (P < 0.01).
Conclusions
There is an increasing trend in therapeutic ERCP utilization in DC hospitalizations nationally. There is an overall decrease in mortality in DC hospitalizations undergoing ERCP. This improvement in mortality suggests improvement in both procedural technique and peri-procedural care as well as overall decreasing mortality in cirrhosis.






Similar content being viewed by others
References
US Burden of Disease Collaborators (2013) The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA 310:591–608. [PubMed: 23842577]
Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB et al (2009) Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol 7:793–799
Park DH, Kim MH, Lee SK et al (2004) Endoscopic sphinctero- tomy vs. endoscopic papillary balloon dilation for chole- docholithiasis in patients with liver cirrhosis and coagulopathy. Gastrointest Endosc 60:180–185
Prat F, Tennenbaum R, Ponsot P et al (1996) Endoscopic sphincterotomy in patients with liver cirrhosis. Gastrointest Endosc 43:127–131
Rakoski MO, McCammon RJ, Piette JD, Iwashyna TJ, Marrero JA, Lok AS et al (2012) Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology 55:184
Del Olmo JA, Garcia F, Serra MA, Maldenodo L, Rodrigo JM (1997) Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol 32:1061–1065
Conte D, Barisani D, Mandelli C, Bodini P, Borzio M, Pistoso S (1991) Cholelithiasis in cirrhosis: analysis of 500 cases. Am J Gastroenterol 86:1629–1632
Kuchipudi V, Chinoy M, Iber FL, Caruso G, Polepalle CH (1990) Increasing prevalence of gallstones in male veterans with alcoholic cirrhosis. Am J Gastroenterol 85:1593–1596
Acalovschi M, Badea R, Pasav M (1991) Incidence of gall- stones in liver cirrhosis. Am J Gastroenterol 86:1179–1181
Sheen I-S, Lian Y-F (1989) The prevalence and incidence of cholecystolithiasis in patients with chronic liver disease: a prospective study. Hepatology 9:538–540
Friedman LS (1999) The risk of surgery in patients with liver disease. Hepatology 29:1617–1623
O’Leary JG, Yachimski PS, Friedman LS (2009) Surgery in the patient with liver disease. Clin Liver Dis 13:211–231
Montomoli J, Erichsen R, Christiansen CF et al (2013) Liver disease and 30- day mortality after colorectal cancer surgery: a Danish population-based cohort study. BMC Gastroenterol 13:66
Inamdar S et al (2016) Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography. Liver Int. https://doi.org/10.1111/liv.13100
Navaneethan U, Njei B, Zhu X, Kommaraju K, Parsi MA, Varadarajulu S (2017) Safety of ERCP in patients with liver cirrhosis: a national database study. Endosc Int Open 5(4):E303–E314. https://doi.org/10.1055/s-0043-102492
Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. [Internet]. HCUP Qual. Control Proced. [cited 2014 Nov 2]; Available from http://www.hcup-us.ahrq.gov/db/quality.pdf. Accessed 2 Nov 2014
Agency for Healthcare Policy and Research. Comparative analysis of HCUP and NHDS inpatient discharge data. [Internet]. Tech. Suppl. 13. NIS release 5 (1996) [cited 2014 Nov 2]; Available from: http://www.ahrq.gov/re- search/data/hcup/nhds/niscomp.html. Accessed 2 Nov 2014
Nehra MS, Ma Y, Clark C, Amarasingham R, Rockey DC, Singal AG (2013) Use of administrative claims data for identifying patients with cirrhosis. J Clin Gastroenterol 47:e50–e54
Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB (2008) The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther 27:274–282
Nadkarni GN et al (2016) National trends of acute kidney injury requiring dialysis in decompensated cirrhosis hospitalizations in the United States. Hepatol Int 10:525–531
Baram D, Daroowalla F, Garcia R, Zhang G, Chen JJ, Healy E et al (2008) Use of the all patient refined-diagnosis related group (APR-DRG) risk of mortality score as a severity adjustor in the medical ICU. Clin Med Circ Respir Pulm Med 2:19–25
Moffatt DC, Yu BN, Yie W, Bernstein CN (2014) Trends in utilization of diagnostic and therapeutic ERCP and cholecystectomy over the past 25 years: a population-based study. Gastrointest Endosc 79:615–622
Moiz A et al (2017) Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): a cross-sectional US experience. Endosc Int Open 5(4):E261–E271. https://doi.org/10.1055/s-0043-102402
Del Olmo JA et al (1997) Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol 32(10):1061–1065
Mercedes V et al (July 2013) Hospital mortality over time in patients with specific complications of cirrhosis. Liver Int 33(6):828–833. https://doi.org/10.1111/liv.12137
Schmidt ML et al (2015) Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology 148(5):967–977, e2, https://doi.org/10.1053/j.gastro.2015.01.032
Buxbaum J et al (2014) Aggressive hydration with lactated ringer’s solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol 12(2):303–307, e1. https://doi.org/10.1016/j.cgh.2013.07.026
Choi J-H et al (2017) Vigorous periprocedural hydration with lactated ringer’s solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients. Clin Gastroenterol Hepatol 15(1):86–92, e1. https://doi.org/10.1016/j.cgh.2016.06.007
Shinju A et al (2010) Post-ERCP pancreatitis. J Hepato-Biliary-Pancreat Sci 17(1):70–78. https://doi.org/10.1007/s00534-009-0220-5
Dumonceau J-M et al (2010) European society of gastrointestinal endoscopy (ESGE) guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 42(6):503–515. https://doi.org/10.1055/s-0029-1244208
Artifon ELA et al (2011) Management of common bile duct stones in cirrhotic patients with coagulopathy: a comparison of supra-papillary puncture and standard cannulation technique. Dig Dis Sci 56(6):1904–1911. https://doi.org/10.1007/s10620-011-1593-2
Mathur AK et al (2017) Hospital resource intensity and cirrhosis mortality in United States. World J Gastroenterol 23(10):1857–1865. https://doi.org/10.3748/wjg.v23.i10.1857
Maurer KR et al (1989) Prevalence of gallstone disease in hispanic populations in the United States. Gastroenterology 96(2 Pt 1):487–492
Everhart JE et al (1999) Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 117(3):632–639
Friedman LS (1999) The risk of surgery in patients with liver disease. Hepatology 29(6):1617–1623. https://doi.org/10.1002/hep.510290639
O’Leary JG, Yachimski PS, Friedman LS (2009) Surgery in the patient with liver disease. Clin Liver Dis 13(2):211–231. https://doi.org/10.1016/j.cld.2009.02.002
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Drs. Dhruv Mehta, Priti Poojari, Aparna Saha, Supreet Kaur, Shanti Patel, Lavneet Chawla, Arun Kumar, Priya Simoes, Deepthi Busayavalasa, Girish Nadkarni, and Madhusudhan Sanaka have no conflicts of interest or financial ties to disclose.
Appendix
Rights and permissions
About this article
Cite this article
Mehta, D., Poojary, P., Saha, A. et al. National trends of endoscopic retrograde cholangiopancreatography utilization and outcomes in decompensated cirrhosis. Surg Endosc 33, 169–178 (2019). https://doi.org/10.1007/s00464-018-6290-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-018-6290-1


